GPR40 Activator 1 is primarily used in research and development within the pharmaceutical and biomedical fields. It is employed to study the activation of the GPR40 receptor, which plays a significant role in glucose metabolism and insulin secretion. This compound is particularly valuable in exploring potential treatments for type 2 diabetes, as activating GPR40 can enhance insulin release in a glucose-dependent manner, offering a safer therapeutic approach compared to traditional treatments. Additionally, it is utilized in preclinical studies to investigate its efficacy, safety, and mechanisms of action, contributing to the development of novel drugs targeting metabolic disorders. Researchers also use it to better understand the signaling pathways and physiological functions associated with GPR40 in various tissues.